Showing results (1-10 of 388) with videos related to

Sort By:
Pageof 39
Biology|April 30, 2021
Inflammatory Markers in Cancer ImmunotherapyDeepak Ravindranathan, Viraj A Master, Mehmet Asim Bilen
Clinical Genitourinary Cancer|February 7, 2018
Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With NivolumabMehmet Asim Bilen, Giselle Marie Almeida Dutcher, Yuan Liu, et al.
Advances in Experimental Medicine and Biology|January 1, 2022
Landscape of Immunotherapy in Genitourinary MalignanciesDeepak Ravindranathan, Omar Alhalabi, Hind Rafei, et al.
Case Reports in Oncological Medicine|May 22, 2018
Metastatic Prostate Cancer Manifesting as Cholestatic Jaundice: A Case Report and Review of the LiteratureDeepak Ravindranathan, Emilie Elise Hitron, Greta Anne Russler, et al.
Case Reports in Oncology|March 29, 2021
Detection of Microsatellite Instability via Circulating Tumor DNA and Response to Immunotherapy in Metastatic Castration-Resistant Prostate Cancer: A Case SeriesDeepak Ravindranathan, Greta Anne Russler, Lauren Yantorni, et al.
The Oncologist|April 24, 2022
Blood-Based Next-Generation Sequencing in Adrenocortical CarcinomaBassel Nazha, Tony Z Zhuang, Hiba I Dada, et al.
The Oncologist|November 25, 2022
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint InhibitorsTony Z Zhuang, Deepak Ravindranathan, Yuan Liu, et al.
Frontiers in Oncology|January 3, 2022
Case Report: Exceptional Response to Nivolumab Plus Ipilimumab in a Young Woman With TFE3-SFPQ Fusion Translocation-Associated Renal Cell CarcinomaDylan J Martini, Caroline S Jansen, Lara R Harik, et al.
Journal for Immunotherapy of Cancer|July 30, 2021
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitorsJacqueline T Brown, Yuan Liu, Julie M Shabto, et al.
The Oncologist|February 26, 2021
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint InhibitorsJacqueline T Brown, Yuan Liu, Julie M Shabto, et al.
Pageof 39